MeSH Browser

MeSH Heading: Sitagliptin Phosphate, Metformin Hydrochloride Drug Combination
Tree Number(s): D02.078.370.141.450.500; D03.383.129.799.725.500; D03.383.679.875.500; D26.310.750
Unique ID: D000068899
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D000068899
Scope Note: A pharmaceutical preparation of sitagliptin phosphate and metformin hydrochloride that is used in the treatment of TYPE 2 DIABETES.
Entry Term(s): Janumet; Sitagliptin Phosphate Metformin Hydrochloride Drug Combination; Sitagliptin Phosphate-Metformin Hydrochloride Drug Combination
Public MeSH Note: 2016; SITAGLIPTIN PHOSPHATE, METFORMIN HYDROCHLORIDE DRUG COMBINATION was indexed under METFORMIN and PYRAZINES 2008-2015
History Note: 2016 (2008)
Date Established: 2016/01/01
Date of Entry: 2015/07/01
Revision Date: 2016/05/31

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analogs & derivatives (AA)

antagonists & inhibitors (AI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Sitagliptin Phosphate, Metformin Hydrochloride Drug Combination MeSH Descriptor Data 2024